SCHEMBL29469645

SCHEMBL29469645

CCOc1ccccc1S(=O)(=O)NC(=O)c1cc2c(F)cc(N3CCC3C(C)(C)O)cc2o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.36
RORC P51449 1/20 0.35
ALDH1A1 P00352 5/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 4/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
ACHE P22303 3/20 0.33
ACLY P53396 1/20 0.33
ALOX5 P09917 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
MRGPRX1 Q96LB2 2/20 0.33
GAA P10253 1/20 0.33
SSTR5 P35346 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24334282 1.00 TP53 (0.36) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL24333740 0.91 TP53 (0.37) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL29469902 0.91 TP53 (0.37) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL29469629 0.89 ALDH1A1 (0.39) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL24334385 0.89 ALDH1A1 (0.39) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL24334384 0.89 ALDH1A1 (0.39) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL29469652 0.88 RORC (0.36) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL24333707 0.88 RORC (0.36) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL24334420 0.86 ALDH1A1 (0.36) TP53RORCALDH1A1MEN1KMT2A
SCHEMBL29469703 0.86 ALDH1A1 (0.36) TP53RORCALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed